Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02016898 · ClinicalTrials.gov registry record · Phase 2

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

A Phase 2 study, sponsored by Duke University.

Completed
Registry status
Phase 2
Development phase
100
Enrollment target

NCT02016898 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02016898, a Phase 2 study, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target

Study Summary

The primary focus of this study is to assess intraocular pressure and complication rates between patients who receive mitomycin-C using a sponge versus no-sponge.

Interventions

  • DRUG Mitomycin-C
  • PROCEDURE Placement of the sponge

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-03
Est. Completion 2017-01-17
Phase Phase 2

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02016898

The ClinicalTrials.gov registry entry for NCT02016898 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mitomycin-C is the first listed.

NCT02016898 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02016898 about?

NCT02016898 is a clinical study titled "The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device". The primary focus of this study is to assess intraocular pressure and complication rates between patients who receive mitomycin-C using a sponge versus no-sponge.

What is the current status of trial NCT02016898?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2014-03. Estimated completion is 2017-01-17.

What interventions are being tested in trial NCT02016898?

The interventions under investigation include: Mitomycin-C (DRUG), Placement of the sponge (PROCEDURE).

Who is sponsoring clinical trial NCT02016898?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.